Weight Loss Outcomes and Long-Term Patterns Weight loss outcomes associated with GLP-1 medications highlight important limitations
Berberine is often compared to GLP-1 receptor agonists in how it affects insulin sensitivity, but the mechanisms are meaningfully different
(Some workplace plans allow you to carry over up to $680.) That means employees who enroll in an FSA during open enrollment, which is typically in November, need to estimate how much theyll spend on health care in the upcoming year
The Reward System Connection Here's where the neuroscience meets everything I teach about reward chemistry hijacking
The case for incretin therapy was once again dismissed in 1950 by Morton Grossman, one of Ivys former students
In addition, fasting in PPAR - null mice resulted in fatty liver disease which was attributed to a decrease in fatty acid oxidation evidenced by low levels of plasma hydroxybutyrate [33, 39, 40]